Cargando…
Recent advances in understanding and managing cystic fibrosis transmembrane conductance regulator dysfunction
Cystic fibrosis is the most common autosomal recessive genetic disease in Caucasians and has been extensively studied for many decades. The cystic fibrosis transmembrane conductance regulator gene was identified in 1989. It encodes a complex protein which has numerous cellular functions. Our underst...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Faculty of 1000 Ltd
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4447040/ https://www.ncbi.nlm.nih.gov/pubmed/26097737 http://dx.doi.org/10.12703/P7-64 |
_version_ | 1782373541444845568 |
---|---|
author | Griesenbach, Uta Alton, Eric W.F.W. |
author_facet | Griesenbach, Uta Alton, Eric W.F.W. |
author_sort | Griesenbach, Uta |
collection | PubMed |
description | Cystic fibrosis is the most common autosomal recessive genetic disease in Caucasians and has been extensively studied for many decades. The cystic fibrosis transmembrane conductance regulator gene was identified in 1989. It encodes a complex protein which has numerous cellular functions. Our understanding of cystic fibrosis pathophysiology and genetics is constantly expanding and being refined, leading to improved management of the disease and increased life expectancy in affected individuals. |
format | Online Article Text |
id | pubmed-4447040 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | Faculty of 1000 Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-44470402015-06-19 Recent advances in understanding and managing cystic fibrosis transmembrane conductance regulator dysfunction Griesenbach, Uta Alton, Eric W.F.W. F1000Prime Rep Review Article Cystic fibrosis is the most common autosomal recessive genetic disease in Caucasians and has been extensively studied for many decades. The cystic fibrosis transmembrane conductance regulator gene was identified in 1989. It encodes a complex protein which has numerous cellular functions. Our understanding of cystic fibrosis pathophysiology and genetics is constantly expanding and being refined, leading to improved management of the disease and increased life expectancy in affected individuals. Faculty of 1000 Ltd 2015-05-27 /pmc/articles/PMC4447040/ /pubmed/26097737 http://dx.doi.org/10.12703/P7-64 Text en © 2015 Faculty of 1000 Ltd http://creativecommons.org/licenses/by-nc/3.0/legalcode All F1000Prime Reports articles are distributed under the terms of the Creative Commons Attribution-Non Commercial License, which permits non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Review Article Griesenbach, Uta Alton, Eric W.F.W. Recent advances in understanding and managing cystic fibrosis transmembrane conductance regulator dysfunction |
title | Recent advances in understanding and managing cystic fibrosis transmembrane conductance regulator dysfunction |
title_full | Recent advances in understanding and managing cystic fibrosis transmembrane conductance regulator dysfunction |
title_fullStr | Recent advances in understanding and managing cystic fibrosis transmembrane conductance regulator dysfunction |
title_full_unstemmed | Recent advances in understanding and managing cystic fibrosis transmembrane conductance regulator dysfunction |
title_short | Recent advances in understanding and managing cystic fibrosis transmembrane conductance regulator dysfunction |
title_sort | recent advances in understanding and managing cystic fibrosis transmembrane conductance regulator dysfunction |
topic | Review Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4447040/ https://www.ncbi.nlm.nih.gov/pubmed/26097737 http://dx.doi.org/10.12703/P7-64 |
work_keys_str_mv | AT griesenbachuta recentadvancesinunderstandingandmanagingcysticfibrosistransmembraneconductanceregulatordysfunction AT altonericwfw recentadvancesinunderstandingandmanagingcysticfibrosistransmembraneconductanceregulatordysfunction |